Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIM1 | GDSC1000 | pan-cancer | AAC | 0.32 | 5e-18 |
mRNA | MFSD2B | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-18 |
mRNA | LEPR | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-18 |
mRNA | ANKRD55 | CCLE | pan-cancer | AAC | 0.41 | 8e-18 |
mRNA | SLC6A19 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-17 |
mRNA | CA1 | GDSC1000 | pan-cancer | AAC | 0.3 | 1e-17 |
mRNA | FAM117A | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-17 |
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-17 |
mRNA | AC104389.1 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-17 |
mRNA | TAL1 | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-17 |